Jesper Paul Fredrik Wiklund

Plus aucun poste en cours

55 ans

Health Technology

Consumer Services

Profil

Jesper Paul Fredrik Wiklund served as the Chief Executive Officer of InDex Pharmaceuticals Holding AB from 2011 to 2015 and also held the position of Chief Executive Officer at Klaria Pharma Holding AB.
Prior to that, he worked as a Principal at Wyeth Pharmaceuticals LLC and as a Manager-Business Development at Elan Pharmaceuticals, LLC.
He also served as the Senior Vice President-Business Development at Evotec SE and as the Vice President-Corporate Development at Swedish Orphan Biovitrum AB.
Mr. Wiklund received his undergraduate degree from St. Mary's College of California and his MBA from Harvard Business School.

Anciens postes connus de Jesper Paul Fredrik Wiklund

Sociétés	Poste	Fin
KLARIA PHARMA HOLDING AB	Chief Executive Officer	-
Wyeth Pharmaceuticals LLC Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.	Corporate Officer/Principal	-
Elan Pharmaceuticals, LLC Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.	Corporate Officer/Principal	-
SWEDISH ORPHAN BIOVITRUM AB	Corporate Officer/Principal	-
EVOTEC SE	Corporate Officer/Principal	-

Voir l'expérience en détail de Jesper Paul Fredrik Wiklund

Formation de Jesper Paul Fredrik Wiklund

St. Mary's College of California	Undergraduate Degree
Harvard Business School	Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées